Narcolepsy Market by Product Type, End User and by Region-Trends and Outlook to 2027

1
Narcolepsy Market
Publication Month Feb 2019  No. of Pages 156
 Report Code TIPRE00003326    Category
Pharmaceuticals
Narcolepsy Market to 2027 - Global Analysis and
Forecasts by Type (Narcolepsy with Cataplexy,
Narcolepsy without Cataplexy, and Secondary
Narcolepsy) Product (Central Nervous System
(CNS) Stimulants, Sodium Oxybate, and
Antidepressants) Distribution Channel (Hospital
Pharmacies and Retail Pharmacies) and Geography
E-Mail  sales_at_theinsightpartners.com
2
Narcolepsy Market
Publication Month Feb 2019  No. of Pages 156
 Report Code TIPRE00003326    Category
Pharmaceuticals
Introduction The relationship between public
health and neurology was not been adequately
explored until recent years. The burden of
neurological disorders have increased
significantly across the world. These disorders
are estimated to affect over a billion population
worldwide, according to the World Health
Organization by 2016. Neurological disorders are
commonly found among all the age groups, in all
geographic populations. Similarly, sleep related
neurological disorders that comprise a large
group of diseases also affect a substantial
population worldwide. These diseases majorly
includes insomnia, sleep apnea, narcolepsy and
others. Key factors driving the market are
rising prevalence of sleep related disorders,
emerging local pharmaceutical biopharmaceutical
companies, and increasing awareness regarding
neurological disorders. However, factors such as
side effects and risks associated with narcolepsy
medications and delayed diagnosis or misdiagnosis
of narcolepsy are likely to restrain the market
growth to a certain extent.
E-Mail  sales_at_theinsightpartners.com
3
Narcolepsy Market
Publication Month Feb 2019  No. of Pages 156
 Report Code TIPRE00003326    Category
Pharmaceuticals
According to a new market research study titled
'Narcolepsy Market - Global Analysis and
Forecasts by Type, Product and Distribution
Channel, the global narcolepsy market is expected
to reach US 4,537.9 Mn in 2027 from US 2,026.8
Mn in 2018. The market is estimated to grow with
a CAGR of 9.5 from 2019-2027. The report
highlights the trends prevalent in the global
narcolepsy market and the factors driving the
market along with those that act as deterrents to
its growth. The report provides a detailed
overview on the industry including both
qualitative and quantitative information. It
provides overview and forecast of the global
Narcolepsy market based on products, application,
and end users. It also provides market size and
forecast till 2027 for overall Narcolepsy market
with respect to five major regions, namely North
America, Europe, Asia-Pacific (APAC), Middle East
and Africa (MEA) and South Central America. The
market by each region is later sub-segmented by
respective countries and segments. The report
covers analysis and forecast of 13 countries
globally along with current trend and
opportunities prevailing in the region.
E-Mail  sales_at_theinsightpartners.com
4
Narcolepsy Market
Publication Month Feb 2019  No. of Pages 156
 Report Code TIPRE00003326    Category
Pharmaceuticals
The report analyzes factors affecting market from
both demand and supply side and further evaluates
market dynamics effecting the market during the
forecast period i.e., drivers, restraints,
opportunities, and future trend. The report also
provides exhaustive PEST analysis for all five
regions namely North America, Europe, APAC, MEA
and South Central America after evaluating
political, economic, social and technological
factors effecting the market in these
regions. The Asia Pacific narcolepsy market is
expected to grow at highest rate during the
forecast period owing higher number of research
development and increasing investments on sleep
related neurological disorders. In addition,
emergence of new local players with competitive
drug portfolio are expected to fuel the market
growth in Asia Pacific region. Get a
PDF Sample copy of Narcolepsy Market https//www.
theinsightpartners.com/sample/TIPRE00003326/
E-Mail  sales_at_theinsightpartners.com
5
Narcolepsy Market
Publication Month Feb 2019  No. of Pages 156
 Report Code TIPRE00003326    Category
Pharmaceuticals

• The List of Companies
• Bioprojet
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals, Inc.
• Graymark Healthcare, Inc.
• Arena Pharmaceuticals, Inc.
• Shire (Acquired by Takeda)
• Ligand Pharmaceuticals, Inc.
• Novartis AG, Mylan N.V.
• Shionogi Inc.
• Inquire more _at_ https//www.theinsightpartners.com/
  inquiry/TIPRE00003326/

E-Mail  sales_at_theinsightpartners.com